Akito Natsume to Humans
This is a "connection" page, showing publications Akito Natsume has written about Humans.
Connection Strength
0.034
-
Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity. Cancer Sci. 2009 Dec; 100(12):2411-8.
Score: 0.011
-
Engineered antibodies of IgG1/IgG3 mixed isotype with enhanced cytotoxic activities. Cancer Res. 2008 May 15; 68(10):3863-72.
Score: 0.010
-
Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region. J Immunol Methods. 2005 Nov 30; 306(1-2):93-103.
Score: 0.008
-
Nonfucosylated anti-CD20 antibody potentially induces apoptosis in lymphoma cells through enhanced interaction with FcgammaRIIIb on neutrophils. Leuk Res. 2010 May; 34(5):666-71.
Score: 0.003
-
IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides. J Immunol Methods. 2005 Nov 30; 306(1-2):151-60.
Score: 0.002